3 hours Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00MarketBeat
Wells Fargo & Company lifted their target price on Acelyrin from $13.00 to $15.00 and gave the company an “overweight” rating in a research note on Wednesday.
Nasdaq 100 · Science · Wells Fargo&Co (WFC)
X